TriSalus Life Sciences (TLSI) Preferred Stock Liabilities (2020 - 2023)
TriSalus Life Sciences (TLSI) posted quarterly Preferred Stock Liabilities of $12.0 million for Q2 2023, down 95.18% year-over-year from $250.0 million in Q2 2022, and down 40.26% quarter-over-quarter from $20.2 million in Q1 2023.
TriSalus Life Sciences (TLSI) Preferred Stock Liabilities (2020 - 2023) Analysis & Trends
TriSalus Life Sciences' Preferred Stock Liabilities history runs 4 years deep, the most recent figure standing at $12.0 million for Q2 2023.
- In Q2 2023, Preferred Stock Liabilities fell 95.18% year-over-year to $12.0 million; the TTM figure through Jun 2023 stood at $12.0 million (down 95.18% YoY), while the FY2022 annual figure was $164.0 million, up 2.18% from the prior year.
- Preferred Stock Liabilities for Q2 2023 stood at $12.0 million, down from $20.2 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $250.0 million in Q2 2022, with the low at $12.0 million in Q2 2023.
- The 4-year median for Preferred Stock Liabilities is $250.0 million (2020), against an average of $183.7 million.
- The sharpest annual moves came in 2022 and 2023: Preferred Stock Liabilities climbed 2.18% in 2022, then sank 95.18% in 2023.
- TriSalus Life Sciences' Preferred Stock Liabilities stood at $250.0 million in 2020, then sank by 35.8% to $160.5 million in 2021, then increased by 2.18% to $164.0 million in 2022, then plunged by 92.66% to $12.0 million in 2023.
- Business Quant data shows TLSI's Preferred Stock Liabilities at $12.0 million in Q2 2023, $20.2 million in Q1 2023, and $164.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 12.05 Mn |
| Mar 31, 2023 | 20.16 Mn |
| Dec 31, 2022 | 164.01 Mn |
| Sep 30, 2022 | 164.01 Mn |
| Jun 30, 2022 | 250.05 Mn |
| Mar 31, 2022 | 250.00 Mn |
| Dec 31, 2021 | 160.51 Mn |
| Sep 30, 2021 | 250.00 Mn |
| Jun 30, 2021 | 250.00 Mn |
| Mar 31, 2021 | 250.00 Mn |
| Dec 31, 2020 | 250.00 Mn |